Login to Your Account



Manufacturing Issue Slows Down Timeline For Decision On Surfaxin

By Aaron Lorenzo


Wednesday, February 2, 2005
Drug manufacturing issues caused investors to dump shares of Discovery Laboratories Inc., dropping the company's stock price by 22 percent Tuesday. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription